increase in the pool and quality of available data. The disadvantage is that treatments that are applicable and effective for one group of patients may not be so for another group of patients. However, a lot of what clinicians do and have accepted as normal practice in SCI is based on what we know about the response of people without SCI to various interventions and care.
Despite the obvious need to look further afield there is still a tendency to ignore what is known from studies conducted on people who do not have SCI, and rely solely on the results of studies involving people with SCI. This may be a mistake, particularly for those interventions that have only been tested on people with SCI in studies that are highly vulnerable to bias. In some situations, we may do better to look at higher quality evidence involving non-SCI populations. The limitations of relying on non-SCI-specific evidence can be captured in the Cochrane GRADE system for evaluating evidence by downgrading evidence for "indirectness" [5] .
With this vision for the future, I welcome the current paper which summarises Cochrane Systematic Reviews and other types of reviews which deal with pressure ulcer management. It draws our attention to what is known about pressure ulcer management from patients with a range of pathologies and emphasises the need for more SCI-specific research on this important topic.
